Growth Differentiation Factor 15 as a Cerebrospinal Fluid Biomarker for the Diagnosis and Prognosis of Leptomeningeal Metastasis.

Ruan H, Li J, Wang F, Zhang L, Luo J, Mu Y, Wang T, Wu Y, Liu J, Ning Y, Deng X, Guan M, Xu J

Open source

DOI
10.1002/ana.78353
Published
2026 Sep 22
Container
Annals of neurology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ana.78353,
  title = {Growth Differentiation Factor 15 as a Cerebrospinal Fluid Biomarker for the Diagnosis and Prognosis of Leptomeningeal Metastasis.},
  author = {Ruan H and Li J and Wang F and Zhang L and Luo J and Mu Y and Wang T and Wu Y and Liu J and Ning Y and Deng X and Guan M and Xu J},
  year = {2026},
  journal = {Annals of neurology},
  doi = {10.1002/ana.78353},
  url = {https://doi.org/10.1002/ana.78353}
}

RIS

TY  - JOUR
TI  - Growth Differentiation Factor 15 as a Cerebrospinal Fluid Biomarker for the Diagnosis and Prognosis of Leptomeningeal Metastasis.
AU  - Ruan H
AU  - Li J
AU  - Wang F
AU  - Zhang L
AU  - Luo J
AU  - Mu Y
AU  - Wang T
AU  - Wu Y
AU  - Liu J
AU  - Ning Y
AU  - Deng X
AU  - Guan M
AU  - Xu J
PY  - 2026
JO  - Annals of neurology
DO  - 10.1002/ana.78353
UR  - https://doi.org/10.1002/ana.78353
ER  - 

APA

H, R., J, L., F, W., L, Z., J, L., Y, M., T, W., Y, W., J, L., Y, N., X, D., M, G., & J, X. (2026). Growth Differentiation Factor 15 as a Cerebrospinal Fluid Biomarker for the Diagnosis and Prognosis of Leptomeningeal Metastasis.. Annals of neurology. https://doi.org/10.1002/ana.78353

Source records